Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.14% | -45.48% | 96.03% | -922.93% | -183.45% |
| Total Depreciation and Amortization | -13.92% | 0.16% | -17.76% | -2.21% | -9.44% |
| Total Amortization of Deferred Charges | 17.73% | -0.65% | 16.44% | -0.38% | 28.85% |
| Total Other Non-Cash Items | 85.75% | -14.25% | -95.56% | 1,882.97% | -10.68% |
| Change in Net Operating Assets | -476.86% | -25.60% | 250.58% | 81.53% | -577.73% |
| Cash from Operations | -81.47% | -22.03% | 24.23% | 894.20% | -93.14% |
| Capital Expenditure | 55.54% | -283.97% | 16.47% | -66.41% | 18.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -137.90% | 20.44% | -14.38% | 24.81% | 2.11% |
| Cash from Investing | -315.83% | 4.83% | -12.25% | 21.86% | 2.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.63% | 115.05% | -75.00% | 132.42% | 48.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -260.87% | -122.12% | 103.60% |
| Cash from Financing | -62.63% | 194.84% | -81.66% | 117.30% | 198.65% |
| Foreign Exchange rate Adjustments | 141.12% | -319.28% | 702.05% | 67.52% | -166.74% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -292.79% | -33.16% | 26.43% | 350.38% | -127.63% |